Corbion N.V.

Amsterdam Stock Exchange CRBN.AS

Corbion N.V. Market Capitalization on January 14, 2025: USD 1.33 B

Corbion N.V. Market Capitalization is USD 1.33 B on January 14, 2025, a 13.63% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Corbion N.V. 52-week high Market Capitalization is USD 1.68 B on September 27, 2024, which is 26.00% above the current Market Capitalization.
Corbion N.V. 52-week low Market Capitalization is USD 1.02 B on January 19, 2024, which is -23.51% below the current Market Capitalization.
Corbion N.V. average Market Capitalization for the last 52 weeks is USD 1.32 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Amsterdam Stock Exchange: CRBN.AS

Corbion N.V.

CEO	Mr. Olivier Rigaud
IPO Date	March 29, 1995
Location	Netherlands
Headquarters	Piet Heinkade 127
Employees	2,727
Sector	Health Care
Industries Biotechnology

Description

Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. The company offers ingredient solutions made from renewable resources for the food, home and personal care, pharmaceutical, animal nutrition, medical device, and bioplastics markets. It markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.

Key trends

Past 5 years